Deep sea water improves hypercholesterolemia and hepatic lipid accumulation through the regulation of hepatic lipid metabolic gene expression

Lee,Kyu‑Shik; Chun,So‑Young; Kwon,Yun‑Suk; Kim,Soyoung; Nam,Kyung‑Soo

doi:10.3892/mmr.2017.6317

Deep sea water improves hypercholesterolemia and hepatic lipid accumulation through the regulation of hepatic lipid metabolic gene expression

Authors:
- Kyu‑Shik Lee
- So‑Young Chun
- Yun‑Suk Kwon
- Soyoung Kim
- Kyung‑Soo Nam
View Affiliations

Affiliations: Department of Pharmacology and Intractable Disease Research Center, School of Medicine, Dongguk University, Gyeongju, Gyeongsangbuk‑do 38066, Republic of Korea
Published online on: March 13, 2017 https://doi.org/10.3892/mmr.2017.6317
Pages: 2814-2822

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

A high‑fat diet or high‑cholesterol diet (HCD) is a major cause of metabolic diseases, including obesity and diabetes; vascular diseases, including hypertension, stroke and arteriosclerosis; and liver diseases, including hepatic steatosis and cirrhosis. The present study aimed to evaluate the effects of deep sea water (DSW) on rats fed a HCD. DSW decreased HCD‑induced increases in total cholesterol and low‑density lipoprotein (LDL) cholesterol in the blood, and recovered high‑density lipoprotein cholesterol. In addition, DSW decreased levels of liver injury markers, which were increased in response to HCD, including glutamate‑oxaloacetate transaminase, glutamate‑pyruvate transferase and alkaline phosphatase. Lower lipid droplet levels were observed in the livers of rats fed a HCD and treated with DSW at a hardness of 1,500, as compared with those in the HCD only group. Semi‑quantitative reverse transcription‑polymerase chain reaction (RT‑PCR) revealed that mRNA expression levels of fatty acid synthase and sterol regulatory element binding protein‑1c (SREBP‑1c) in rats fed a HCD with DSW were lower compared with the HCD only group. Furthermore, quantitative RT‑PCR revealed that DSW enhanced LDL receptor (LDLR) mRNA expression in a hardness‑dependent manner. Combined, the results of the present study indicated that DSW may reduce HCD‑induced increases in blood and liver lipid levels, indicating that DSW may protect against hypercholesterolemia and non‑alcoholic hepatic steatosis. In addition, the present study demonstrated that DSW‑induced downregulation of lipids in the blood and hepatic lipid accumulation was mediated by enhancement of LDLR expression and suppression of fatty acid synthase and SREBP‑1c.

View Figures

View References

1	Ma Y, Wang W, Zhang J, Lu Y, Wu W, Yan H and Wang Y: Hyperlipidemia and atherosclerotic lesion development in Ldlr-deficient mice on a long-term high-fat diet. PLoS One. 7:e358352012. View Article : Google Scholar : PubMed/NCBI
2	Zhang X, Wu C, Wu H, Sheng L, Su Y, Zhang X, Luan H, Sun G, Sun X, Tian Y, et al: Anti-hyperlipidemic effects and potential mechanisms of action of the caffeoylquinic acid-rich Pandanus tectorius fruit extract in hamsters fed a high fat-diet. PLoS One. 8:e619222013. View Article : Google Scholar : PubMed/NCBI
3	Daniels SR: Management of hyperlipidemia in pediatrics. Curr Opin Cardiol. 27:92–97. 2012. View Article : Google Scholar : PubMed/NCBI
4	Cholesterol Treatment Trialists' (CTT) Collaboration. Baigent C, Blackwell L, Emberson J, Holland LE, Reith C, Bhala N, Peto R, Barnes EH, Keech A, et al: Efficacy and safety of more intensive lowering of LDL cholesterol: A meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet. 376:1670–1681. 2010. View Article : Google Scholar : PubMed/NCBI
5	Berry JD, Dyer A, Cai X, Garside DB, Ning H, Thomas A, Greenland P, Van Horn L, Tracy RP and Lloyd-Jones DM: Lifetime risks of cardiovascular disease. N Engl J Med. 366:321–329. 2012. View Article : Google Scholar : PubMed/NCBI
6	Harchaoui KE, Visser ME, Kastelein JJ, Stroes ES and Dallinga-Thie GM: Triglycerides and cardiovascular risk. Curr Cardiol Rev. 5:216–222. 2009. View Article : Google Scholar : PubMed/NCBI
7	Yang ZH, Miyahara H, Takeo J, Hatanaka A and Katayama M: Pollock oil supplementation modulates hyperlipidemia and ameliorates hepatic steatosis in mice fed a high-fat diet. Lipids Health Dis. 10:1892011. View Article : Google Scholar : PubMed/NCBI
8	Yao Z, Liu XC and Gu YE: Schisandra chinensis Baill, a Chinese medicinal herb, alleviates high-fat-diet-inducing non-alcoholic steatohepatitis in rats. Afr J Tradit Complement Altern Med. 11:222–227. 2013.PubMed/NCBI
9	Carrier B, Wen S, Zigouras S, Browne RW, Li Z, Patel MS, Williamson DL and Rideout TC: Alpha-lipoic acid reduces LDL-particle number and PCSK9 concentrations in high-fat fed obese Zucker rats. PLoS One. 9:e908632014. View Article : Google Scholar : PubMed/NCBI
10	Singh AB, Kan CF, Shende V, Dong B and Liu J: A novel posttranscriptional mechanism for dietary cholesterol-mediated suppression of liver LDL receptor expression. J Lipid Res. 55:1397–1407. 2014. View Article : Google Scholar : PubMed/NCBI
11	Kim H, Bartley GE, Arvik T, Lipson R, Nah SY, Seo K and Yokoyama W: Dietary supplementation of chardonnay grape seed flour reduces plasma cholesterol concentration, hepatic steatosis, and abdominal fat content in high-fat diet-induced obese hamsters. J Agric Food Chem. 62:1919–1925. 2014. View Article : Google Scholar : PubMed/NCBI
12	Kim S, Chun SY, Lee DH, Lee KS and Nam KS: Mineral-enriched deep-sea water inhibits the metastatic potential of human breast cancer cell lines. Int J Oncol. 43:1691–1700. 2013.PubMed/NCBI
13	Katsuda S, Yasukawa T, Nakagawa K, Miyake M, Yamasaki M, Katahira K, Mohri M, Shimizu T and Hazama A: Deep-sea water improves cardiovascular hemodynamics in Kurosawa and Kusanagi-Hypercholesterolemic (KHC) rabbits. Biol Pharm Bull. 31:38–44. 2008. View Article : Google Scholar : PubMed/NCBI
14	Lee KS, Shin JS, Kwon YS, Moon DS and Nam KS: Suppression of cancer progression and metastasis in HT-29 human colorectal adenocarcinomas by deep sea water. Biotechnol Bioproc Eng. 18:194–200. 2013. View Article : Google Scholar
15	Fu ZY, Yang FL, Hsu HW and Lu YF: Drinking deep seawater decreases serum total and low-density lipoprotein-cholesterol in hypercholesterolemic subjects. J Med Food. 15:535–541. 2012. View Article : Google Scholar : PubMed/NCBI
16	Ha BG, Shin EJ, Park JE and Shon YH: Anti-diabetic effect of balanced deep-sea water and its mode of action in high-fat diet induced diabetic mice. Mar Drugs. 11:4193–4212. 2013. View Article : Google Scholar : PubMed/NCBI
17	Hataguchi Y, Tai H, Nakajima H and Kimata H: Drinking deep-sea water restores mineral imbalance in atopic eczema/dermatitis syndrome. Eur J Clin Nutr. 59:1093–1096. 2005. View Article : Google Scholar : PubMed/NCBI
18	Hsu CL, Chang YY, Chiu CH, Yang KT, Wang Y, Fu SG and Chen YC: Cardiovascular protection of deep-seawater drinking water in high-fat/cholesterol fed hamsters. Food Chem. 127:1146–1152. 2011. View Article : Google Scholar : PubMed/NCBI
19	Hwang HS, Kim HA, Lee SH and Yun JW: Anti-obesity and antidiabetic effects of deep sea water on ob/ob mice. Mar Biotechnol (NY). 11:531–539. 2009. View Article : Google Scholar : PubMed/NCBI
20	Hwang HS, Kim SH, Yoo YG, Chu YS, Shon YH, Nam KS and Yun JW: Inhibitory effect of deep-sea water on differentiation of 3T3-L1 adipocytes. Mar Biotechnol (NY). 11:161–168. 2009. View Article : Google Scholar : PubMed/NCBI
21	Li PC, Pan CH, Sheu MJ, Wu CC, Ma WF and Wu CH: Deep sea water prevents balloon angioplasty-induced hyperplasia through MMP-2: An in vitro and in vivo study. PLoS One. 9:e969272014. View Article : Google Scholar : PubMed/NCBI
22	Miyamura M, Yoshioka S, Hamada A, Takuma D, Yokota J, Kusunose M, Kyotani S, Kawakita H, Odani K, Tsutsui Y and Nishioka Y: Difference between deep seawater and surface seawater in the preventive effect of atherosclerosis. Biol Pharm Bull. 27:1784–1787. 2004. View Article : Google Scholar : PubMed/NCBI
23	Sheu MJ, Chou PY, Lin WH, Pan CH, Chien YC, Chung YL, Liu FC and Wu CH: Deep sea water modulates blood pressure and exhibits hypolipidemic effects via the AMPK-ACC pathway: An in vivo study. Mar Drugs. 11:2183–2202. 2013. View Article : Google Scholar : PubMed/NCBI
24	Yoshioka S, Hamada A, Cui T, Yokota J, Yamamoto S, Kusunose M, Miyamura M, Kyotani S, Kaneda R, Tsutsui Y, et al: Pharmacological activity of deep-sea water: Examination of hyperlipemia prevention and medical treatment effect. Biol Pharm Bull. 26:1552–1559. 2003. View Article : Google Scholar : PubMed/NCBI
25	Reitman S and Frankel S: A colorimetric method for the determination of serum glutamic oxalacetic and glutamic pyruvic transaminases. Am J Clin Pathol. 28:56–63. 1957. View Article : Google Scholar : PubMed/NCBI
26	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
27	Vuppalanchi R and Chalasani N: Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Selected practical issues in their evaluation and management. Hepatology. 49:306–317. 2009. View Article : Google Scholar : PubMed/NCBI
28	Inoue M, Ohtake T, Motomura W, Takahashi N, Hosoki Y, Miyoshi S, Suzuki Y, Saito H, Kohgo Y and Okumura T: Increased expression of PPARgamma in high fat diet-induced liver steatosis in mice. Biochem Biophys Res Commun. 336:215–222. 2005. View Article : Google Scholar : PubMed/NCBI
29	Chen IS, Chang YY, Hsu CL, Lin HW, Chang MH, Chen JW, Chen SS and Chen YC: Alleviative effects of deep-seawater drinking water on hepatic lipid accumulation and oxidation induced by a high-fat diet. J Chin Med Assoc. 76:95–101. 2013. View Article : Google Scholar : PubMed/NCBI
30	Ma PT, Gil G, Südhof TC, Bilheimer DW, Goldstein JL and Brown MS: Mevinolin, an inhibitor of cholesterol synthesis, induces mRNA for low density lipoprotein receptor in livers of hamsters and rabbits. Proc Natl Acad Sci USA. 83:8370–8374. 1986. View Article : Google Scholar : PubMed/NCBI
31	Yasunobu Y, Hayashi K, Shingu T, Nomura K, Ohkura Y, Tanaka K, Kuga Y, Nomura S, Ohtani H, Nishimura T, et al: Reduction of plasma cholesterol levels and induction of hepatic LDL receptor by cerivastatin sodium (CAS 143201-11-0, BAY w 6228), a new inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, in dogs. Cardiovasc Drugs Ther. 11:567–574. 1997. View Article : Google Scholar : PubMed/NCBI
32	Abad C, Vargas FR, Zoltan T, Proverbio T, Piñero S, Proverbio F and Marín R: Magnesium sulfate affords protection against oxidative damage during severe preeclampsia. Placenta. 36:179–185. 2015. View Article : Google Scholar : PubMed/NCBI
33	Olatunji LA and Soladoye AO: Increased magnesium intake prevents hyperlipidemia and insulin resistance and reduces lipid peroxidation in fructose-fed rats. Pathophysiology. 14:11–15. 2007. View Article : Google Scholar : PubMed/NCBI
34	Gupta M, Solanki MH, Chatterjee PK, Xue X, Roman A, Desai N, Rochelson B and Metz CN: Maternal magnesium deficiency in mice leads to maternal metabolic dysfunction and altered lipid metabolism with fetal growth restriction. Mol Med. 20:332–340. 2014. View Article : Google Scholar : PubMed/NCBI
35	Niranjan G, Anitha D, Srinivasan AR, Velu VK, Venkatesh C, Babu MS, Ramesh R and Saha S: Association of inflammatory sialoproteins, lipid peroxides and serum magnesium levels with cardiometabolic risk factors in obese children of South Indian population. Int J Biomed Sci. 10:118–123. 2014.PubMed/NCBI
36	Jacqmain M, Doucet E, Després JP, Bouchard C and Tremblay A: Calcium intake, body composition, and lipoprotein-lipid concentrations in adults. Am J Clin Nutr. 77:1448–1452. 2003.PubMed/NCBI
37	Miyake S: The mechanism of release of hepatic enzymes in various liver diseases. II. Altered activity ratios of GOT to GPT in serum and liver of patients with liver diseases. Acta Med Okayama. 33:343–358. 1979.PubMed/NCBI
38	Cremers J, Drent M, Driessen A, Nieman F, Wijnen P, Baughman R and Koek G: Liver-test abnormalities in sarcoidosis. Eur J Gastroenterol Hepatol. 24:17–24. 2012. View Article : Google Scholar : PubMed/NCBI
39	Morán-Salvador E, López-Parra M, García-Alonso V, Titos E, Martínez-Clemente M, González-Périz A, López-Vicario C, Barak Y, Arroyo V and Clària J: Role for PPARγ in obesity-induced hepatic steatosis as determined by hepatocyte- and macrophage-specific conditional knockouts. FASEB J. 25:2538–2550. 2011. View Article : Google Scholar : PubMed/NCBI
40	Deng Q, Li X, Fu S, Yin L, Zhang Y, Wang T, Wang J, Liu L, Yuan X, Sun G, et al: SREBP-1c gene silencing can decrease lipid deposits in bovine hepatocytes cultured in vitro. Cell Physiol Biochem. 33:1568–1578. 2014. View Article : Google Scholar : PubMed/NCBI
41	Chang XX, Yan HM, Xu Q, Xia MF, Bian H, Zhu TF and Gao X: The effects of berberine on hyperhomocysteinemia and hyperlipidemia in rats fed with a long-term high-fat diet. Lipids Health Dis. 11:862012. View Article : Google Scholar : PubMed/NCBI
42	Benn T, Kim B, Park YK, Yang Y, Pham TX, Ku CS, Farruggia C, Harness E, Smyth JA and Lee JY: Polyphenol-rich blackcurrant extract exerts hypocholesterolaemic and hypoglycaemic effects in mice fed a diet containing high fat and cholesterol. Br J Nutr. 113:1697–1703. 2015. View Article : Google Scholar : PubMed/NCBI
43	Zhao Y, Peng L, Yang LC, Xu XD, Li WJ, Luo XM and Jin X: Wedelolactone regulates lipid metabolism and improves hepatic steatosis partly by AMPK Activation and Up-regulation of expression of PPARα/LPL and LDLR. PLoS One. 10:e01327202015. View Article : Google Scholar : PubMed/NCBI